Otto-von-Guericke-Universitaet Magdeburg

Magdeburg 39120

1 studies enrolling now · 7 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Bradycardia, Congenital Hyperinsulinism, Heart Failure, Hepatocellular Carcinoma, Hepatocellular Carcinoma Surveillance, Obesity, Overweight, Sinus Node Dysfunction

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) — Running, not enrolling
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• Strategic Management to Optimize Response To Cardiac Resynchronization Therapy — Completed
• Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma — Completed
• Safety and Performance Study of the INGEVITY Lead — Completed